Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bode: Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous.... (0.14 sec) 

Comparison of insulin aspart with buffered regular insulin and insulin lispro in …

- diabetesjournals.org
B Bode, R Weinstein, D Bell, J McGill, D Nadeau, P … - Diabetes Care, 2002 - Am Diabetes Assoc
RESULTS—Treatment groups had similar baseline HbA 1c (7.3% ±0.7 for IAsp, 7.5% ±0.8 for
BR, and 7.3% ±0.7 for lispro). After 16 weeks of treatment, HbA 1c values were relatively unchanged
from baseline, and the mean changes in baseline HbA 1c values were not significantly ...
Cited by 122 - Related articles - BL Direct - All 20 versions

Efficacy, safety, and pump compatibility of insulin aspart used in continuous …


BW Bode, P Strange - Diabetes Care, 2001 - Am Diabetes Assoc
OBJECTIVE— The purpose of this study was to compare the efficacy, safety, and pump compatibility
of insulin aspart (a rapid-acting insulin analog) and buffered regular human insulin in patients
with type 1 diabetes undergoing continuous subcutaneous insulin infusion (CSII) therapy.
Cited by 83 - Related articles - BL Direct - All 13 versions

[PDF] Use of insulin lispro in continuous subcutaneous insulin infusion treatment


R Renner, A Pfutzner, M Trautmann, O Harzer, K … - Diabetes care, 1999 - Am Diabetes Assoc
C ontinuous subcutaneous insulin infu- sion (CSII) with insulin pump devices is, to date, the besttherapeuticoption
to achieve near- no rmal blood glucose con- t rol. Inpart icular, distinct subgroups of dia- betic
patients may especially benefit fro m CSII. These groups are patients with low insulin re ...
Cited by 149 - Related articles - BL Direct - All 6 versions

A direct comparison of insulin aspart and insulin lispro in patients with type 1 …

- diabetesjournals.org
J Plank, A Wutte, G Brunner, A Siebenhofer, B … - Diabetes Care, 2002 - Am Diabetes Assoc
RESULTS—With respect to blood glucose excursions from time 0 to 6 h (Exc glu(0–6 h) ) and
from time 0 to 4 h (Exc glu(0–4 h) ), the pharmacodynamic effect of insulin aspart and insulin
lispro can be declared equivalent. This was supported by comparison with maximum ...
Cited by 76 - Related articles - BL Direct - All 6 versions

A comparison of insulin lispro and buffered regular human insulin administered via …


P Raskin, JH Holcombe, WV Tamborlane, JI … - Journal of diabetes and its …, 2001 - Elsevier
This study compared glycemic control achieved with insulin lispro or buffered regular human
insulin in patients with Type 1 diabetes treated with continuous subcutaneous insulin infusion
(CSII) using an external insulin pump. In this 24-week multicenter, randomized, two-way ...
Cited by 65 - Related articles - BL Direct - All 11 versions

[PDF] Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the …


P Raskin, RA Guthrie, L Leiter, A Riis, L Jovanovic - Diabetes Care, 2000 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS — This was a randomized open-label parallel-group
study conducted at 59 centers in the US and Canada. Sub- jects with type 1 diabetes were treated
with IAsp or HI as part of an intensive insulin reg- imen for 6 months, and then could ...
Cited by 196 - Related articles - BL Direct - All 7 versions

Are analogue insulins better than soluble in continuous subcutaneous insulin …


J Colquitt, P Royle, N Waugh - Diabetic Medicine, 2003 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 61 - Related articles - BL Direct - All 4 versions

Post-prandial administration of the insulin analogue insulin aspart in patients with …


GA Brunner, S Hirschberger, G Sendlhofer, A … - Diabetic …, 2000 - interscience.wiley.com
Aims In intensified insulin therapy, the recent development of short-acting insulin analogues
with a very rapid onset of action forces a new discussion in terms of the optimal injection–meal
interval. This study evaluated prandial glycaemia in patients with Type 1 diabetes ...
Cited by 63 - Related articles - BL Direct - All 6 versions

Insulin aspart vs. human insulin in the management of long-term blood glucose …


PD Home, A Lindholm, A Riis - Diabetic Medicine, 2000 - ingentaconnect.com
Methods Prospective, multi-centre, randomized, open-labelled, parallel-group trial lasting 6 months
in 88 centres in eight European countries and including 1070 adult subjects with Type 1
diabetes. Study patients were randomized 2:1 to insulin aspart or unmodi®ed human ...
Cited by 117 - Related articles - BL Direct - All 4 versions

Human insulin analogue [LYS (B28), PRO (B29)]: the ideal pump insulin


S Schmau, A König, R Landgraf - Diabetic Med, 1998 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 44 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google